| An enlightened conversation about vaccination, health and autonomy |
| “You may choose to look the other way, but you can never say again that you did not know.” —William Wilberforce |
IN THE NEWSGrassroots Resistance in Europe and Australia to Vaccine Mandates and Lockdowns Escalate as COVID Vaccines FailNovember 30, 2021 | Risk & Failure Reports Despite nearly two years of persistent public protests in major cities in Europe and Australia, the governments currently in power have declined to respond to the deep concerns of significant numbers of people living in western democracies, who are opposed to the suspension of civil liberties associated with COVID-19 vaccine mandates and lockdowns.Read More > | OPINIONRenewable Travel Pass May Signal Annual Booster Shots for European UnionNovember 29, 2021 | Opinion As part of an effort to reopen their borders and encourage travelers from outside of Europe, the 27 member states of the European Union (E.U.) began issuing an “E.U. Digital COVID Certificate” (EUDCC) on July 1, 2021 to people who have receive COVID vaccinations to allow freedom of movement within the region. The travel scheme, also known as an “immunity pass” or a “health pass” or a “green pass,” was first announced by the E.U. on Apr. 14, 2021 and was approved by the European..Read More > |
VACCINATIONEfficacy of Pfizer’s COVID Biologic Estimated at 33 PercentNovember 29, 2021 | Risk & Failure Reports A recent study soon to be published in the Journal of Medical Biochemistry found that Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19 significantly loses its efficacy within six months of the second shot. Researchers from the University of Verona in Italy and Cincinnati Children’s Hospital Medical Center in Ohio looked at 787 health care workers in Verona, Italy between the ages of 21 and 75 years old and found that their…Read More > | BUSINESSMerck and Pfizer Seek Approval for COVID-19 Antiviral DrugsNovember 29, 2021 | Pharma Merck and Pfizer have submitted Emergency Use Authorization (EUA) applications to the U.S. Food and Drug Administration (FDA) to authorize distribution of what would be the first antiviral drug specifically designed to treat COVID-19 disease. Merck/Ridgeback Biotherapeutics are seeking EUA approval for Molnupiravir (MK-4482/EIDD-2801), an investigational oral antiviral drug originally developed to treat…Read More > |
| BEST IN VIDEO |
Protests Erupt Across Europe Over COVID Rules and LockdownsNovember 29, 2021 | Best in Video “A number of European countries have been looking at a new COVID rules and lockdowns, and those changes led to protests in Vienna, Brussels, Zurich and Amsterdam this weekend. Really, the epicenter of the crisis so far is Austria, which has entered its fourth national lockdown due to the current pandemic wave. People have been asked to work from home, while all non-essential shops will be closed. According the the chancellor, Alexander Schallenberg, the lockdown would run for a maximum of 20 days.”View Video > |
| The Vaccine ReactionNVIC is an independent, charitable non-profit 501(c)(3) organization founded in 1982. NVIC does notaccept donations or grants from pharmaceutical corporations, medical trade groups, government agencies, or foundations marketing vaccine products or promoting mandated use of vaccines. |
| National Vaccine Information Center21525 Ridgetop Circle, Ste 100,Sterling, VA 20166703-938-0342 |
Unorthodox Truth 